Back to search

Article

Molecular Mechanisms of Targeted Therapy Resistance in Genitourinary Tumors: A Path to New Therapeutic Horizons

2025-06-12

Abstract excerpt

Targeted therapies have transformed the treatment of genitourinary (GU) malignancies, particularly renal cell carcinoma (RCC), offering significant clinical benefits. However, therapy resistance, driven by intrinsic tumor characteristics and acquired mechanisms, frequently limits their effectiveness. This review comprehensively examines targeted therapies in GU tumors, focusing on their clinical impact and the mol...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
177d1c9e-2f8a-5a2b-bef5-74bdbd9f6290
DOI
10.20944/preprints202506.1000.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular Mechanisms of Targeted Therapy Resistance in Genitourinary Tumors: A Path to New Therapeutic HorizonsDOI 10.20944/preprints202506.1000.v1
Immune Checkpoint Inhibitor Resistance in Genitourinary Cancers: Mechanisms, Biomarkers, and Emerging Therapeutic StrategiesSemantic proximity
Management of advanced bladder cancer in the era of targeted therapies.Semantic proximity
lncRNA and Mechanisms of Drug Resistance in Cancers of the Genitourinary SystemSemantic proximity
Deciphering resistance mechanisms in cancer: final report of MATCH-R study with a focus on molecular drivers and PDX development.Semantic proximity
Distinct Molecular Profiles and Drug Vulnerabilities in Pancreatic Metastases of Renal Cell CarcinomaSemantic proximity
Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapiesSemantic proximity
Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies.Semantic proximity
Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancerSemantic proximity
Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor ProgressionSemantic proximity
Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomesSemantic proximity
Treatment strategies for clear cell renal cell carcinoma: Past, present and futureSemantic proximity
Advanced papillary renal cell carcinoma: Epidemiology, genomic drivers, current therapies, and ongoing trials.Semantic proximity
Select a neighboring publication to make it the new centre.